Fudan Cancer Center’s Urologic Team Pioneers a “Gradient Treatment” Model
Five-Year Survival Rates for Three Major Urologic Cancers Reach World-Class Levels, Bringing the “Chinese Approach” to Global Patients From record-breaking survival outcomes in precision-targeted therapy for urothelial carcinoma, to consecutive…









